Form 4: Elanco Executive Sells Shares for Tax Obligations

Sentiment:

Insider Transaction Report


An Elanco Animal Health Inc. executive disposed of 6,492 common shares to cover tax withholding obligations at a price of $24.88 per share.

Summary

  • Ramiro Martin Cabral, Executive Vice President Elanco International at Elanco Animal Health Inc. (ELAN), reported a transaction.
  • On March 3, 2026, Mr. Cabral disposed of 6,492 shares of Elanco Common Stock.
  • The disposition was made at a price of $24.88 per share.
  • This transaction was coded 'F', indicating a disposition to the issuer to satisfy tax withholding obligations.
  • Following this transaction, Mr. Cabral beneficially owns 283,874 shares of Common Stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. The transaction is a routine disposition for tax withholding purposes, which is a common practice and does not reflect a change in the company's operational or financial performance.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

StockSavvy.ai notes that insider transactions, particularly dispositions for tax withholding, are common occurrences in publicly traded companies, especially when executive compensation includes equity awards. This specific transaction by an Elanco executive is a routine compliance filing and does not inherently signal a change in company fundamentals or strategic direction within the animal health industry.

Related Party Transactions

  • Ramiro Martin Cabral, an Executive Vice President of Elanco Animal Health Inc., disposed of shares of the company's common stock, which constitutes an insider transaction.

Stakeholder Impact

  • Shareholders: This routine transaction is unlikely to have a significant direct impact on shareholders, as it's a common practice for executive equity compensation.

Key Dates

DateDescription
03/03/2026Date of transaction where 6,492 shares were disposed of.
03/05/2026Date the Form 4 filing was signed.

Keywords

Elanco Animal Health, ELAN, Insider Trading, Form 4, Stock Sale, Tax Withholding, Executive Compensation

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.